Pfizer executives recount COVID-19 efforts for remote chamber audience
20 May 2021
With its highly effective COVID-19 vaccine in wide use around the world, Pfizer hardly is resting on its laurels.
A COVID-19 pill pioneered last year at the company’s Groton labs is now in clinical trials at its New Haven facility, Pfizer executives noted Wednesday during a Zoom presentation to members of the Chamber of Commerce of Eastern Connecticut.
The new oral version of the vaccine, which works by blocking an enzyme that enables the COVID-19 virus to replicate, could help keep people from getting the disease as well as provide some relief from its effects, said John Burkhardt, a Pfizer senior vice president and head of the Groton labs.